[Rabson-Mendenhall syndrome].
Ishiki
Manabu
M
First Department of Internal Medicine, Faculty of Medicine, Toyama Medical & Pharmaceutical University.
Kobayashi
Masashi
M
D000015:Abnormalities, Multiple / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D000052:Acanthosis Nigricans / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D003937:Diagnosis, Differential; D004700:Endocrine System Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D006801:Humans; D006965:Hyperplasia / Q000175:diagnosis; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use; D009154:Mutation; D009264:Nails, Malformed / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D018126:Odontodysplasia / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D010870:Pineal Gland / Q000473:pathology*; D011379:Prognosis; D011972:Receptor, Insulin / Q000235:genetics; D011994:Recombinant Proteins / Q000627:therapeutic use; D013577:Syndrome
D011994:Recombinant Proteins; D007334:Insulin-Like Growth Factor I; D011972:Receptor, Insulin